• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化TNM系统以用于分化型甲状腺癌的临床应用。

Simplifying the TNM system for clinical use in differentiated thyroid cancer.

作者信息

Onitilo Adedayo A, Engel Jessica M, Lundgren Catharina Ihre, Hall Per, Thalib Lukman, Doi Suhail A R

机构信息

Marshfield Clinic Weston Center, Weston, WI, USA.

出版信息

J Clin Oncol. 2009 Apr 10;27(11):1872-8. doi: 10.1200/JCO.2008.20.2382. Epub 2009 Mar 9.

DOI:10.1200/JCO.2008.20.2382
PMID:19273697
Abstract

PURPOSE

The TNM stratification has been found useful at stratifying patients with differentiated thyroid carcinoma (DTC) into prognostic risk groups. However, it is cumbersome to implement clinically given the large number of bins within this system and the complicated system of arriving at stage information.

PATIENTS AND METHODS

We decided to quantify each variable in this system to arrive at a simplified quantitative alternative to the TNM system (QTNM) and compare this with the conventional system. We used our electronic record system to identify 614 cases of DTC managed at our institution from 1987 to 2006. Cancer-specific survival (CSS) and disease-free survival (DFS) were calculated by the Kaplan-Meier method, and a simplified QTNM score was devised using a Cox proportional hazards model.

RESULTS

We were able to quantify the TNM system as follows: 4 points each for age older than 45 years and presence of neck nodal metastases while 6 points for tumor size larger than 4 cm or extrathyroidal extension and 1 point for nonpapillary DTC. A sum of 0 to 5 points was low risk, 6 to 10 points intermediate, and 11 to 15 points high risk. Comparison with the conventional TNM system and two other systems revealed similar or better discrimination with the QTNM and this discrimination was maintained when this risk stratification was applied to a unique validation set.

CONCLUSION

The QTNM system as opposed to the conventional TNM system seems to be a simple and effective method for risk stratification for both recurrence and cancer-specific mortality.

摘要

目的

已发现TNM分层有助于将分化型甲状腺癌(DTC)患者分为不同的预后风险组。然而,鉴于该系统内有大量分类以及获取分期信息的复杂系统,在临床实施时较为繁琐。

患者与方法

我们决定对该系统中的每个变量进行量化,以得出TNM系统的简化定量替代方案(QTNM),并将其与传统系统进行比较。我们使用电子记录系统识别了1987年至2006年在我们机构接受治疗的614例DTC病例。采用Kaplan-Meier法计算癌症特异性生存率(CSS)和无病生存率(DFS),并使用Cox比例风险模型设计了简化的QTNM评分。

结果

我们能够对TNM系统进行如下量化:年龄大于45岁和存在颈部淋巴结转移各得4分,肿瘤大小大于4 cm或甲状腺外侵犯得6分,非乳头状DTC得1分。总分0至5分为低风险,6至10分为中度风险,11至15分为高风险。与传统TNM系统及其他两个系统的比较显示,QTNM具有相似或更好的区分度,并且当将这种风险分层应用于一个独特的验证集时,这种区分度得以维持。

结论

与传统TNM系统相比,QTNM系统似乎是一种用于复发和癌症特异性死亡率风险分层的简单有效的方法。

相似文献

1
Simplifying the TNM system for clinical use in differentiated thyroid cancer.简化TNM系统以用于分化型甲状腺癌的临床应用。
J Clin Oncol. 2009 Apr 10;27(11):1872-8. doi: 10.1200/JCO.2008.20.2382. Epub 2009 Mar 9.
2
Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.预后因素及风险分组在分化型甲状腺癌管理中的意义
Laryngoscope. 2004 Mar;114(3):393-402. doi: 10.1097/00005537-200403000-00001.
3
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.滤泡性甲状腺癌的分期系统:应用于一家三级转诊中心连续治疗的171例患者。
Endocr Relat Cancer. 2007 Mar;14(1):29-42. doi: 10.1677/erc.1.01284.
4
AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.甲状腺乳头状癌中的AMES、MACIS和TNM预后分类。
Anticancer Res. 2003 Sep-Oct;23(5b):4283-8.
5
Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.验证由肿瘤微血管侵犯、大小和分级组成的术后预后模型,以预测接受手术切除的肾细胞癌患者的无病生存期和癌症特异性生存期。
Int J Urol. 2009 Jul;16(7):616-21. doi: 10.1111/j.1442-2042.2009.02319.x. Epub 2009 May 13.
6
Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.采用美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)第六版TNM分期系统对分化型甲状腺癌进行再分期:分期迁移与可预测性。
Ann Surg Oncol. 2007 May;14(5):1551-9. doi: 10.1245/s10434-006-9242-2. Epub 2007 Feb 21.
7
Prognostic factors determining survival in differentiated thyroid cancer.决定分化型甲状腺癌生存的预后因素。
J Surg Oncol. 2007 Dec 1;96(7):598-604. doi: 10.1002/jso.20845.
8
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.验证 QTNM 分期系统在分化型甲状腺癌患者中的癌症特异性生存预测价值。
Endocrine. 2014 Jun;46(2):300-8. doi: 10.1007/s12020-013-0078-9. Epub 2013 Oct 31.
9
A comparison of prognostic classification systems for differentiated thyroid carcinoma.分化型甲状腺癌的预后分类系统比较。
Clin Endocrinol (Oxf). 2010 Jun;72(6):830-8. doi: 10.1111/j.1365-2265.2009.03734.x. Epub 2009 Oct 31.
10
Need for a revised staging consensus in medullary thyroid carcinoma.甲状腺髓样癌分期共识修订的必要性。
Arch Surg. 2009 Jul;144(7):663-9. doi: 10.1001/archsurg.2009.122.

引用本文的文献

1
A user-friendly nomogram for predicting radioiodine refractory differentiated thyroid cancer.用于预测放射性碘难治性分化型甲状腺癌的用户友好型列线图。
Front Endocrinol (Lausanne). 2023 Feb 10;14:1109439. doi: 10.3389/fendo.2023.1109439. eCollection 2023.
2
High RPMB predicts poor disease-free survival of male N1 papillary thyroid cancer after adjuvant radioiodine therapy.高复发/转移风险分层(RPMB)预示着男性N1期乳头状甲状腺癌患者辅助放射性碘治疗后的无病生存期较差。
Heliyon. 2022 Nov 19;8(11):e11783. doi: 10.1016/j.heliyon.2022.e11783. eCollection 2022 Nov.
3
Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature.
低风险甲状腺癌的管理:主动监测是一种有效的选择吗?文献系统综述
J Clin Med. 2021 Aug 13;10(16):3569. doi: 10.3390/jcm10163569.
4
Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer.放射性碘(碘化物)在分化型甲状腺癌管理中的放射诊断学范例。
Curr Pharm Des. 2020;26(31):3812-3827. doi: 10.2174/1381612826666200605121054.
5
Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?对于甲状腺乳头状癌滤泡变体,简化的TNM分期系统是否比美国癌症联合委员会系统更具临床相关性?
Ann Transl Med. 2020 Apr;8(7):463. doi: 10.21037/atm.2020.03.111.
6
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
7
Is there a need for yet another staging system for differentiated thyroid cancer?对于分化型甲状腺癌,是否还需要另一种分期系统?
Endocrine. 2014 Jun;46(2):179-80. doi: 10.1007/s12020-014-0203-4. Epub 2014 Feb 16.
8
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.验证 QTNM 分期系统在分化型甲状腺癌患者中的癌症特异性生存预测价值。
Endocrine. 2014 Jun;46(2):300-8. doi: 10.1007/s12020-013-0078-9. Epub 2013 Oct 31.
9
A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.基于监测、流行病学和最终结果(SEER)登记处,对美国癌症联合委员会(AJCC)用于年轻分化型甲状腺癌患者的分期系统进行批判性分析。
Surgery. 2012 Aug;152(2):145-51. doi: 10.1016/j.surg.2012.02.015. Epub 2012 Apr 11.
10
Cancer: QTNM: a simplified TNM or just another staging system?
Nat Rev Endocrinol. 2009 Oct;5(10):531-2. doi: 10.1038/nrendo.2009.181.